The novel approach of the medication represents a exciting advance in the handling of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide358686.bloggadores.com/40773686/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment